GW-627368X - CAS# 439288-66-1 ry of Histone Demethylase Treatment with Anacetrapib leads to

Treatment with Anacetrapib leads to significant increases in HDL-C levels at day 0

BPTES has a K(i) of approx

Cobalt chloride induces RhoA/ROCK activation and remodeling effect in H9c2 cardiomyoblasts: Involvement of PI3K/Akt and MAPK pathways

CAS Number: 127191-97-3

ROCK inhibitor-2

GW-627368X - CAS# 439288-66-1 ry of Histone Demethylase Treatment with Anacetrapib leads toGW 627368X, CAS No. 439288 66 1, is a novel, potent and selective competitive antagonist of prostanoid EP4 receptors with additional human TP receptor affinity. Oral administration of GW627368X showed significant tumor regression characterized by tumor reduction and induction of apoptosis. Reduction in prostaglandin E2 synthesis also led to reduced level of VEGF in plasma. GW627368X will be a valuable tool to explore the role of the prostanoid EP4